BCG vaccination in the cotton rat (Sigmodon hispidus) infected by the pulmonary route with virulent Mycobacterium tuberculosis.
To evaluate the usefulness of the American cotton rat (Sigmodon hispidus) in the evaluation of vaccine-induced resistance, we infected BCG-vaccinated and non-vaccinated cotton rats with Mycobacterium tuberculosis (H37Rv) via the respiratory route. Lung histopathology of these animals showed loose, disorganized granulomas which were non-necrotic up to 8 weeks post-infection. Moreover, we were not able to detect a DTH response after intradermal injection with PPD antigen. Prior BCG vaccination significantly reduced lung and spleen bacterial loads by 1-1.5log CFU and upregulated PPD-induced proliferation and production of IFNgamma in lymphocyte cultures. We conclude that pulmonary infection of the cotton rat with Mtb more closely resembles the phenotype seen in mice rather than guinea pigs.
McFarland
Christine T
CT
Department of Microbial and Molecular Pathogenesis, Texas A&M Health Science Center, College Station, TX 77843-1114, USA.
Ly
Lan
L
Jeevan
Amminikutty
A
Yamamoto
Toshiko
T
Weeks
Bradley
B
Izzo
Angelo
A
McMurray
David
D
D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000276:immunology; D058491:Bacterial Load; D049109:Cell Proliferation; D002478:Cells, Cultured; D004195:Disease Models, Animal; D005260:Female; D006099:Granuloma / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007371:Interferon-gamma / Q000096:biosynthesis; D008168:Lung / Q000382:microbiology; D008297:Male; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity*; D016205:Sigmodontinae; D013154:Spleen / Q000276:immunology / Q000382:microbiology; D014373:Tuberculin / Q000276:immunology; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D014611:Vaccination / Q000379:methods; D014774:Virulence
D000336:Aerosols; D001500:BCG Vaccine; D014373:Tuberculin; D007371:Interferon-gamma
Tuberculosis (Edinb). 2007 Mar;87(2):155-65
17289434
J Virol. 2005 Dec;79(23):14632-9
16282463
Expert Rev Vaccines. 2008 Jul;7(5):635-50
18564018
Infect Immun. 1998 Jun;66(6):2951-9
9596772
Am Rev Respir Dis. 1970 Dec;102(6):937-49
4991996
J Virol. 2007 Sep;81(17):9443-50
17596309
Scand J Infect Dis. 2001;33(3):175-8
11303805
Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S35-47
18762152
J Bacteriol. 1967 Oct;94(4):832-5
4964472
Tuberculosis (Edinb). 2001;81(1-2):141-6
11463235
J Gen Virol. 2005 Oct;86(Pt 10):2823-2830
16186238
Lab Anim. 2002 Oct;36(4):357-72
12396279
Infect Immun. 1983 Oct;42(1):81-7
6352505
Cell Microbiol. 2007 May;9(5):1127-36
17217432
Am Rev Respir Dis. 1970 Sep;102(3):422-9
5450906
Tuberculosis (Edinb). 2003;83(1-3):112-5
12758199
J Infect Dis. 2002 Dec 15;186(12):1713-7
12447755
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):13-7
15687022
Virology. 2005 Jun 20;337(1):102-10
15914224
PLoS One. 2010 Apr 21;5(4):e10289
20422019
Appl Microbiol. 1973 May;25(5):718-23
4577173
J Interferon Cytokine Res. 2004 Jan;24(1):21-8
14980081
Tuberculosis (Edinb). 2005 Jul;85(4):245-58
15958260
Tuberculosis (Edinb). 2009 Mar;89(2):183-8
19223233
Am J Respir Cell Mol Biol. 2008 Nov;39(5):503-8
18556589
Tuberculosis (Edinb). 2007 Mar;87(2):145-54
16973421
J Infect Dis. 2007 Jun 1;195(11):1634-42
17471433
Infect Immun. 2003 Dec;71(12):7035-42
14638793
Trends Mol Med. 2001 Mar;7(3):135-7
11286786
Indian J Exp Biol. 2009 Jun;47(6):440-4
19634708